Published

US FDA approves AstraZeneca's self-administered nasal spray flu vaccine

  • The U.S. Food and Drug Administration approved the first flu vaccine for self-administration on Friday; however, it will not be available for this respiratory virus season.
  • This approval provides a second option for those eligible, allowing adults or children with help to take the vaccine at home.
  • AstraZeneca plans to distribute the vaccine through a third-party online pharmacy, making it available for next year’s respiratory virus season.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 77% of the sources are Center
77% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)